Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
Ovarian clear cell carcinoma (OCCC) is associated with chemotherapy resistance and poor prognosis, especially in advanced cases. Although comprehensive genomic analyses have clarified the significance of genomic alterations such as <i>ARID1A</i> and <i>PIK3CA</i> mutations in...
Main Authors: | Ryo Tamura, Kosuke Yoshihara, Takayuki Enomoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/9/2125 |
Similar Items
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
by: Tsukuru Amano, et al.
Published: (2021-01-01) -
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
by: Wei Chen, et al.
Published: (2020-08-01) -
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
by: Tadahiro Shoji, et al.
Published: (2021-12-01) -
Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part I. The pathophysiology of thrombosis and hypercoagulation
by: E. N. Lipets, et al.
Published: (2015-10-01) -
Ovarian clear cell carcinoma with bilateral breast metastasis
by: Aashita, et al.
Published: (2023-01-01)